Windlas Biotech Profit & Loss Annual

BSE: 543329 | NSE: WINDLAS | ISIN: INE0H5O01029 | Sector: Biotechnology & Drugs

947.95 -44.60 (-4.49%)Updated : 09 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	830.09	693.38	566.23	465.22
Other Net	-0.03	0.51	0.37	0.42
Diluted Weighted Average Shares	2.13	2.11	2.09	2.16
Depreciation/ Amortization	30.74	27.99	13.44	12.36
Operating Income	74.00	66.49	64.73	47.86
Net Income	66.46	60.99	58.19	42.63
Income Availableto Com Excl Extra Ord	66.46	60.99	58.19	42.63
Other Operating Expenses Total	3.66	2.44	2.57	1.89
Net Income Before Taxes	86.98	79.76	77.09	57.04
Minority Interest	0.00	0.00	0.00	0.00
Net Income After Taxes	66.46	60.99	58.19	42.63
Income Availableto Com Incl Extra Ord	66.46	60.99	58.19	42.63
Costof Revenue Total	585.53	493.47	412.33	338.35
Gross Profit	318.56	266.41	218.63	174.73
Interest Inc( Exp) Net- Non- Op Total	13.01	12.75	11.99	7.88
Diluted Net Income	66.46	60.99	58.19	42.63
DPS- Common Stock Primary Issue	6.30	5.80	5.50	4.00
Provisionfor Income Taxes	20.52	18.76	18.90	14.41
period Type	-	-	-	-
Net Income Before Extra Items	66.46	60.99	58.19	42.63
Total Revenue	904.09	759.88	630.96	513.08
period Length	12.00	12.00	12.00	12.00
Revenue	904.09	759.88	630.96	513.08
Selling/ General/ Admin Expenses Total	201.81	163.24	130.01	103.66
Diluted Normalized EPS	31.15	28.87	27.87	19.40
Research Development	8.34	6.25	7.88	8.95
Diluted EPS Excluding Extra Ord Items	31.15	28.87	27.88	19.70
Gain( Loss)on Saleof Assets	-	0.01	0.01	0.88
Unusual Expense( Income)	-	-	0.00	0.01